YD Bio Ltd business relationships

Companies named in YD Bio Ltd’s 20-F filed 2026-04-30, and public companies whose annual reports name YD Bio Ltd. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 4.0 / 10
AI naming: <1 / 100
Agent readiness: 10 / 100
AI adoption: 0 / 100

Named in YD Bio Ltd’s annual report 5

NOVARTIS AG (NVS)Customer7.7
“Novartis, Zuelling and Alcon - accounted for approximately 53.7% of the company's total revenue for the year ended December” SEC filing
NOVARTIS AG (NVS)Partner7.7
“global pharmaceutical companies such as Novartis and Alcon, as well as having licensing partnerships with EG BioMed for pancreatic and” SEC filing
ALCON INC (ALC)Customer6.6
“Novartis, Zuelling and Alcon - accounted for approximately 53.7% of the company's total revenue for the year ended December” SEC filing
ALCON INC (ALC)Partner6.6
“global pharmaceutical companies such as Novartis and Alcon, as well as having licensing partnerships with EG BioMed for pancreatic and” SEC filing
ALCON INC (ALC)Supplier6.6
“Alcon, as a supplier of clinical testing drugs.” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.